As of now, the FDA has set deadlines for compounders to stop producing tirzepatide products, but it is not enforcing the deadlines at the moment as the lawsuit is ongoing
Weight loss injections approved by the FDA for chronic weight management include semaglutide (Wegovy) and tirzepatide (Zepbound)
Medication, dose, and compounded formulation are determined by your clinician based on intake responses, eligibility, and state availability
2020 Oct;46(4):1347-1358
This approval is based on studies showing that the combination can help people lose weight when used alongside a reduced-calorie diet and increased physical activity
The generated LC-MS raw data were processed with Spectronaut (version 18.5.231110) (Biognosys) using the standard settings of the directDIA workflow, except that quantification was performed on MS1, with a human SwissProt database (www.uniprot.org, 20422 entries)